Infectious Diseases Market Research Reports & Industry Analysis
Infectious Diseases Industry Research & Market Reports
-
Rapid Diagnostics Market by Product (Kits [OTC, Professional], Readers), Platform (Lateral Flow, Serological, PCR), Application (Blood Glucose, Infectious Diseases, Pregnancy, Drugs of Abuse), End User (Hospitals, Diagnostic Labs, Home Care) - Global Forecast to 2029
... Rapid Diagnostics Market by Product (Kits [OTC, Professional], Readers), Platform (Lateral Flow, Serological, PCR), Application (Blood Glucose, Infectious Diseases, Pregnancy, Drugs of Abuse), End User (Hospitals, Diagnostic Labs, Home Care) — Global Forecasts to 2029 ... Read More
-
Vaccine Adjuvants Market Forecasts to 2028 – Global Analysis By Type (Virus-like Particles, Tensoactive Adjuvants, Organic Adjuvants), Product (Adjuvant Emulsions, Combination Adjuvants), Disease Type (Cancer, Infectious Diseases) and By Geography
... Global Vaccine Adjuvants Market is accounted for $791.00 million in 2021 and is expected to reach $2,040.87 million by 2028 growing at a CAGR of 14.5% during the forecast period. Adjuvants are fundamentally compounds that ... Read More
-
Monoclonal Antibodies Market Size By Type (Fully Human, Humanized, Chimeric), By Application (Oncology, Autoimmune Diseases, Infectious Diseases), By End-use (Hospitals, Specialty Centers), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028
... - 2028 The monoclonal antibodies market would expand at a progressive CAGR through 2028 owing to the rising incidence of infectious, chronic, and rare diseases, including cancer, across the globe. As per the WHO, cancer ... Read More
-
Medical Device Regulatory Affairs Market By Services (Regulatory consulting /Strategic Services, Regulatory writing and publishing, Legal representation, Product Registration and Clinical trials, Others), By Service Provider (In-House, Out sourcing), By Types (Diagnostic, Therapeutics), By Indication (Infectious Diseases, Oncology and Hematology, Gynaecology and Obstetrics, Muscusloskeletal Disorders, Respiratory, Cardiovascular, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
... (Infectious Diseases, Oncology and Hematology, Gynaecology and Obstetrics, Muscusloskeletal Disorders, Respiratory, Cardiovascular, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031 The global Medical Device Regulatory Affairs Market was valued at $6,969.7 million in 2021, and ... Read More
-
Antibody Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Products (Kits, Chemical & reagents, and Consumables), Indication (Pregnancy, Cardiovascular Diseases, Autoimmune Diseases, Infectious Diseases, Oncology, Endocrine Diseases, and Others), End User (Hospitals, Academic and Research Institutes, Diagnostic Laboratories, and Biopharmaceutical Companies)
... (Hospitals, Academic and Research Institutes, Diagnostic Laboratories, and Biopharmaceutical Companies) The global antibody testing market was valued at US$ million 7,260.00 in 2021 and is projected to reach US$ 11,578.47 million by 2028; it is ... Read More
-
Influenza A Virus, H3N2 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... H3N2 Subtype Infections - Drugs In Development, 2022, provides an overview of the Influenza A Virus, H3N2 Subtype Infections (Infectious Disease) pipeline landscape. H3N2 infections are caused by variant H3N2 virus which is an influenza ... Read More
-
Ventilator Associated Pneumonia (VAP) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Ventilator Associated Pneumonia (VAP) Clinical trials scenario. This report provides top line data ... Read More
-
Europe Infectious Disease Diagnostics Market - Country-Wise Analysis: Focus on Product, Testing Location, Infectious Disease Type, Infection Type, Technology, and End User - Analysis and Forecast, 2021-2031
... Market Segmentation Product (system, kits and reagents, and software) Testing location (laboratory testing and point-of-care testing) Technology (next-generation sequencing (NGS), polymerase chain reaction (PCR), immunodiagnostics, isothermal nucleic acid amplification technology (INAAT), microarray, in-situ hybridization (ISH), ... Read More
-
2022 Global Forecast for Hospital Acquired Infection Control (2023-2028 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales ... Read More
-
Diagnostic Specialty Antibodies Market by Type (Primary, Secondary), Clonality (Monoclonal, Polyclonal), Technique (WB, Rapid Test, IHC, IP), Conjugate, and Application (Dengue, Malaria, Hepatitis, HIV, E. coli , Tuberculosis, Pneumonia, Cancer)- Forecast to 2029
... Antibodies Market by Type (Primary, Secondary), Clonality (Monoclonal, Polyclonal), Technique (WB, Rapid Test, IHC, IP), Conjugate, and Application (Dengue, Malaria, Hepatitis, HIV, E. coli , Tuberculosis, Pneumonia, Cancer)- Forecast to 2029 The diagnostic specialty antibodies ... Read More
-
South and Central America Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)
... Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The South & Central America monoclonal antibodies market is expected to reach US$ 10,847.3 million by ... Read More
-
Europe Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... and End User (Pediatric, ICU, Home Care, and Others) The Europe non-invasive ventilation masks market is expected to reach US$ 735.24 million by 2028 from US$ 515.45 million in 2021. The market is estimated to ... Read More
-
North America Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Others), and End User (Pediatric, ICU, Home Care, and Others) The North America non-invasive ventilation masks market is expected to reach US$ 985.8 million by 2028 from US$ 671.1 million in 2021. The market is ... Read More
-
South and Central America Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others) The South & Central America non-invasive ventilation masks market is expected to reach US$ 166.2 million by 2028 from US$ 119.8 million in ... Read More
-
Middle East and Africa Non-Invasive Ventilation Masks Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Non-Invasive Ventilation Reusable Masks and Non-Invasive Ventilation Disposable Masks), Application (Respiratory Dysfunction, Chronic Obstructive Pulmonary Diseases, Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others)
... Pneumonia, and Others), and End User (Pediatric, ICU, Home Care, and Others) The Middle East & Africa non-invasive ventilation masks market is expected to reach US$ 114.0 million by 2028 from US$ 84.2 million in ... Read More
-
Middle East and Africa Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)
... Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The Middle East & Africa monoclonal antibodies market is expected to reach US$ 5,741.1 million by ... Read More
-
Exosome Research Market by Product and services (Kits, Reagents, Instrument), Indication (Cancer, Infectious Diseases), Application (Biomarkers, Vaccines), Manufacturing Services (Stem cell, Dendritic cell-derived), End User - Global Forecast to 2026
... valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences ... Read More
-
Asia Pacific Monoclonal Antibodies Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Source (Human, Humanized, Chimeric, and Murine), Production Method (In-Vitro, and In-Vivo), Indication (Cancer, Autoimmune Diseases, Infectious Diseases, Inflammatory Diseases, Microbial Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others)
... Diseases, and Others), Application (Therapeutic Applications, Diagnostic Applications, and Research Applications), End-User (Hospitals, Research Institutes, and Others) The Asia Pacific monoclonal antibodies market is expected to reach US$ 44,729.7 million by 2028 from US$ 18,344.5 ... Read More
-
Hospital-Acquired Infection Diagnostics Market By Product (Instrument, Reagents and Consumables), By Test Type (Molecular Diagnostics, Immunoassay, Others), By Application (Disease Testing, Drug-Resistance Testing), By Infection Type (Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections (UTI), Others), By End User (Hospital, Standalone Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2021-2030
... Infections, Urinary Tract Infections (UTI), Others), By End User (Hospital, Standalone Laboratories, Others): Global Opportunity Analysis and Industry Forecast, 2021-2030 The global hospital acquired infection diagnostics market was valued $3,355.28 million in 2020 and expected ... Read More
-
Infectious Disease Diagnostic Testing: World Market Analysis
... microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the responsible pathogen, pinpoint its origin, and determine an ... Read More
-
2022 Global Clinical Risk Grouping Solutions Industry (2028 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2016-2019), a three-year forecast estimate trends (2020-2023), and a five-year outlook projection (2023-2028) for 46 countries. Market and product shipments include ... Read More
-
Ventilator Associated Pneumonia (VAP) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Ventilator Associated Pneumonia (VAP) (Infectious Disease) pipeline landscape. Ventilator-associated pneumonia (VAP) is pneumonia that develops ... Read More
-
Community Acquired Pneumonia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Community Acquired Pneumonia (Infectious Disease) pipeline landscape. Community-acquired pneumonia (CAP) is defined as pneumonia acquired outside a ... Read More
-
Smallpox Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Smallpox (Infectious Disease) pipeline landscape. Smallpox is an acute contagious infection caused by the Variola virus. Symptoms include fever, malaise, headache, ... Read More
-
Hospital Acquired Pneumonia (HAP) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an overview of the Hospital Acquired Pneumonia (HAP) (Infectious Disease) pipeline landscape. Hospital Acquired Pneumonia (HAP) is defined as ... Read More
Research Assistance
